Volume 13, Number 3—March 2007
Escherichia coli Cluster Evaluation
Highlight and copy the desired format.
|EID||Johnson JR. Escherichia coli Cluster Evaluation. Emerg Infect Dis. 2007;13(3):520. https://dx.doi.org/10.3201/eid1303.041085|
|AMA||Johnson JR. Escherichia coli Cluster Evaluation. Emerging Infectious Diseases. 2007;13(3):520. doi:10.3201/eid1303.041085.|
|APA||Johnson, J. R. (2007). Escherichia coli Cluster Evaluation. Emerging Infectious Diseases, 13(3), 520. https://dx.doi.org/10.3201/eid1303.041085.|
To the Editor: Gupta et al. raise important issues regarding molecular profiling as an epidemiologic tool (1). First, since all living organisms are related, the goal of genomic profiling in public health epidemiology is not really to determine “whether such isolates are truly related” (1) (they are), but to define the degree of similarity—or, more specifically, to determine whether isolates are sufficiently closely related that the probability of their deriving immediately from the same point source is high enough to warrant epidemiologic investigation. Second, definitive assessment of genetic similarity relationships is challenging because of the limited accuracy and resolving power of conventional methods such as pulsed-field gel electrophoresis (PFGE) analysis (2) and the impracticality and expense of better performing technologies. Sequential use of multiple methods (such as PFGE with additional restriction enzymes) will predictably detect additional differences, thereby improving resolving power (2). Third, even if genetic similarity could be precisely defined, the relationship between the degree of genetic similarity and the probability of point-source spread is unknown and doubtless varies in relation to pretest probability, depending on the epidemiologic context (e.g., localized vs. multistate clusters). Even <100% similarity may be compatible with point-source spread when genetic drift exists within the reservoir, leading to dissemination of highly similar but nonidentical clones.
Gupta et al. interpret their experience as indicating that, with geographically dispersed isolates, a higher degree of genomic similarity than is reliably provided by single-enzyme PFGE is necessary to improve specificity, thereby avoiding fruitless investigative efforts (1). However, whether the subclusters shown by their second-round PFGE were more epidemiologically meaningful than the original cluster remains unclear, nor do we know how representative this experience is. Determination of optimal genetic similarity parameters for geographically distributed epidemiologic surveillance (e.g., through PulseNet) would seem to require more in-depth empirical assessment, possibly incorporating Bayesian likelihood (3).
- Gupta A, Hunter SB, Bidol SA, Dietrich S, Kincaid J, Salehi E, Escherichia coli O157 cluster evaluation.Emerg Infect Dis. 2004;10:1856–8.
- Davis MA, Hancock DD, Better TE, Call DR. Evaluation of pulsed-field gel electrophoresis as a tool for determining the degree of genetic relatedness between strains of Escherichia coli O157:H7.J Clin Microbiol. 2003;41:1843–9.
- Gardner IA. An epidemiologic critique of current microbial risk assessment practices: the importance of prevalence and test accuracy data.J Food Prot. 2004;67:2000–7.
Please use the form below to submit correspondence to the authors or contact them at the following address:
James R. Johnson, VA Medical Center, Infectious Diseases (111F), Rm 3B-101 1 Veterans Dr, Minneapolis, MN 55417, USA;
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: June 29, 2010
- Page last updated: June 29, 2010
- Page last reviewed: June 29, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)